The pathophysiology of photosensitivity in lupus erythematosus

Photodermatology Photoimmunology and Photomedicine

Volumn 17, Issue 3, 2001, Pages 95-113

  Orteu, Catherine H ^a   Sontheimer, Richard D ^b   Dutz, Jan P ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

Author keywords

Apoptosis; Heat shock protein; Lupus erythematosus; Photosensitivity; TNF

Indexed keywords

COMPLEMENT COMPONENT C2; COMPLEMENT COMPONENT C4; INTERLEUKIN 1; INTERLEUKIN 10; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; CYTOLOGY; DISEASE ASSOCIATION; HEREDITY; HUMAN; HUMAN CELL; HUMAN TISSUE; KERATINOCYTE; LUPUS ERYTHEMATOSUS; MOLECULAR BIOLOGY; PATHOGENESIS; PATHOPHYSIOLOGY; PHOTOREACTIVITY; PHOTOSENSITIVITY; PRIORITY JOURNAL; REVIEW; SKIN DEFECT; SUNLIGHT; ULTRAVIOLET RADIATION;

HUMANS; LUPUS ERYTHEMATOSUS, CUTANEOUS; PHOTOSENSITIVITY DISORDERS;

EID: 0035021630     PISSN: 09054383     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0781.2001.170301.x     Document Type: Review

References (295)

1. Dermatologic lupus: Hopkins Lupus Cohort
2. Lupus erythematosus in the 1980s: A survey of 570 patients
3. Pierre Cazenave and the first detailed modern description of lupus erythematosus
4. Disease related to light sensitivity
5. Prevalence and expression of photosensitivity in systemic lupus erythematosus
6. Phototesting and photoprotection in LE
7. Subacute cutaneous lupus erythematosus during PUVA therapy for psoriasis: Case report and review of the literature
8. An exacerbation of SLE after visiting a tanning salon
9. Seasons of the year and activity of SLE and Behcets-disease
10. Influence of seasons on risk of flare-up of systemic lupus: Retrospective study of 66 patients
11. Light sensitivity in lupus erythematosus
12. Photobiology of lupus erythematosus
13. Action spectra of lupus erythematosus and experimental immunofluorescence
14. Phototests in patients with various forms of lupus erythematosus
15. Photosensitivity in systemic lupus erythematosus: Laboratory testing of ARA/ACR definition
16. Wavelength dependence of oxidative DNA damage induced by UV and visible light
17. Cutaneous lesions of lupus erythematosus induced by monochromatic light
18. Action spectrum and mechanism of UV-radiation induced injury in lupus erythematosus
19. Standardized ultraviolet A exposure provokes skin reaction in systemic lupus erythematosus
20. Experimental reproduction of skin lesions in lupus erythematosus by UVA and UVB radiation
21. Diagnosis and management of systemic lupus erythematosus. Sun protection is vital
22. Photosensitivity in lupus
23. Lichenoid tissue reactions. A speculative review of the clinical spectrum of epidermal basal cell damage with special reference to erythema dyschromicum perstans
24. The lichenoid reaction pattern
25. The influence of ultraviolet light on immunological cytotoxicity in the skin
26. Apoptosis in the pathogenesis of cutaneous lupus erythematosus
27. Keratinocyte apoptosis and p53 expression in cutaneous lupus and dermatomyositis
28. Immunohistochemical detection of proliferation and differentiation in discoid lupus erythematosus
29. Phototesting in lupus erythematosus
30. Epidermal Langerhans cell involvement in cutaneous lupus erythematosus
31. Immunopathology of cutaneous human lupus erythematosus defined by murine monoclonal antibodies
32. Immunopathologic study of lichenoid skin diseases: Correlation between HLA-DR-positive keratinocytes or Langerhans cells and epidermotropic T cells
33. Immunohistochemical analysis of chronic discoid and subacute cutaneous lupus erythematosus-relation to immunopathological mechanisms
34. Chronic discoid lupus erythematosus: An immunopathological and electron microscopic study
35. Pathology, immunopathology, and immunohistochemistry in cutaneous lupus erythematosus
36. Cutaneous localization of human gamma-globulins in lupus erythematosus. An electron-microscopical study using the peroxidase-labeled antibody technique
37. The significance of cutaneous immunoglobulin deposits in lupus erythematosus and NZB/NZW F1 hybrid mice
38. Apoptosis as the mechanism of the involution of hair follicles in catagen transformation
39. Accumulation of gamma delta T cells in chronic cutaneous lupus erythematosus
40. Thy-1 and T-cell receptor antigen expression in mycosis fungoides and benign inflammatory dermatoses
41. Selective expansions of T cells expressing V beta 8 and V beta 13 in skin lesions of patients with chronic cutaneous lupus erythematosus
42. T cell receptor clonotypes in skin lesions from patients with systemic lupus erythematosus
43. In situ expression of B7 and CD28 receptor families in skin lesions of patients with lupus erythematosus
44. Failed self-tolerance and autoimmunity in IgG anti-DNA transgenic mice
45. Induction of a systemic lupus erythematosus-like disease in mice by a common human anti-DNA idiotype
46. Experimental renal disease induced by DNA-anti-DNA immune complexes
47. Experimental skin lesions in mice resembling systemic lupus erythematosus
48. DNA damage and repair in human skin: Pathways and questions
49. Repair of ultraviolet B and singlet oxygen-induced DNA damage in xeroderma pigmentosum cells
50. Processing of directly and indirectly ultraviolet-induced DNA damage in human cells
51. Immunological detection of thymidine photoproduct formation in vivo
52. Ultraviolet light alteration of cellular deoxyribonucleic acid in vivo
53. Antigen binding characteristics of experimentally-induced antibodies against hydroxyl radical modified native DNA
54. Immunogenicity of DNA damaged by reactive oxygen species-implications for anti-DNA antibodies in lupus
55. Antibodies to UV light denatured DNA in systemic lupus erythematosus: Detection by filter radioimmunoassay and clinical correlations
56. Disruption of keratin intermediate filaments by ultraviolet radiation in cultured human keratinocytes
57. Ultraviolet light induces binding of antibodies to selected nuclear antigens on cultured human keratinocytes
58. Binding of antibodies to the extractable nuclear antigens SS-A/Ro and SS-B/La is induced on the surface of human keratinocytes by ultraviolet light (UVL): Implications for the pathogenesis of photosensitive cutaneous lupus
59. Enhanced membrane binding of autoantibodies to cultured keratinocytes of systemic lupus erythematosus patients after ultraviolet B/ultraviolet A irradiation
60. Rapid lupus autoantigen relocalization and reactive oxygen species accumulation following ultraviolet irradiation of human keratinocytes
61. Fas ligand and Bax gene transcription contributes to Ro60 ribonucleoprotein redistribution in UV-A irradiated human keratinocytes
62. Expression of SS-A/Ro and SS-B/La antigens in skin biopsy specimens of patients with photosensitive forms of lupus erythematosus
63. IgG subclasses in the serum and skin in subacute cutaneous lupus erythematosus and neonatal lupus erythematosus
64. Deposition of membrane attack complex in cutaneous lesions of lupus erythematosus
65. The use of antibody to C5b-9 in the subclassification of lupus erythematosus
66. Pathomechanisms of photosensitive lupus erythematosus
67. Susceptibility to UVB light in cultured keratinocytes of cutaneous lupus erythematosus
68. Antinuclear antibody-keratinocyte interactions in photosensitive cutaneous lupus erythematosus
69. Keratinocytes from patients with lupus erythematosus show enhanced cytotoxicity to ultraviolet radiation and to antibody-mediated cytotoxicity
70. The role of RNP, Sm, and SS-A/Ro-specific antisera from patients with lupus erythematosus in inducing antibody-dependent cellular cytotoxicity (ADCC) of targets coated with nonhistone nuclear antigens
71. Distribution of natural killer cells and lymphocyte subclasses in Jessner's lymphocytic infiltration of the skin and in cutaneous lesions of discoid and systemic lupus erythematosus
72. Immunohistopathology of light-induced skin lesions in lupus erythematosus
73. Ultraviolet light-induced keratinocyte apoptosis: A potential mechanism for the induction of skin lesions and autoantibody production in LE
74. Toward an understanding of the molecular mechanisms of physiological cell death
75. Phagocyte recognition of cells undergoing apoptosis
76. Apoptosis. Phagocytic docking without shocking
77. Light and death: Photons and apoptosis
78. Preprogrammed and programmed cell death mechanisms of apoptosis: UV-induced immediate and delayed apoptosis
79. Death receptors: Signaling and modulation
80. DNA damaging agents induce expression of Fas ligand and subsequent apoptosis in T lymphocytes via the activation of NF-kappa B and AP-1
81. Cellular environments and apoptosis: Tissue microenvironments control activated T-cell death
82. Interleukin-2 receptor common gamma-chain signaling cytokines regulate activated T cell apoptosis in response to growth factor withdrawal: Selective induction of anti-apoptotic (bcl-2, bcl-xL) but not expression
83. Interferon-beta mediates stromal cell rescue of T cells from apoptosis
84. The role of apoptosis in the resolution of T cell-mediated cutaneous inflammation
85. Epidermal tissue homeostasis: Apoptosis and cell emigration as mechanisms of controlled cell deletion in the epidermis of the toad, Bufo bufo
86. Programmed cell death in terminally differentiating keratinocytes: Role of endogenous endonuclease
87. Communication: Expression of the novel inhibitor of apoptosis survivin in normal and neoplastic skin
88. IAP family proteins-suppressors of apoptosis
89. Histochemical responses of human skin following ultraviolet radiation
90. UVA1 radiation triggers two different final apoptotic pathways
91. Ultraviolet light induces apoptosis via direct activation of CD95 (Fas/APO-1) independently of its ligand CD95L
92. Fas ligand: A sensor for DNA damage critical in skin cancer etiology
93. Ultraviolet-B-induced apoptosis of keratinocytes: Evidence for partial involvement of tumor necrosis factor-alpha in the formation of sunburn cells
94. TNF receptor p55 plays a pivotal role in murine keratinocyte apoptosis induced by ultraviolet B irradiation
95. Nuclear and cell membrane effects contribute independently to the induction of apoptosis in human cells exposed to UVB radiation
96. p53-mediated protective responses to UV irradiation
97. p53-regulated apoptosis is differentiation dependent in ultraviolet B-irradiated mouse keratinocytes
98. Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes
99. Autoimmunity and apoptosis
100. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs
101. DNA-dependent protein kinase is one of a subset of autoantigens specifically cleaved early during apoptosis
102. Life and death decisions: Regulation of apoptosis by proteolysis of signaling molecules
103. The fate of U1 snRNP during anti-Fas induced apoptosis: Specific cleavage of the U1 snRNA molecule
104. Rapid nucleolytic degradation of the small cytoplasmic Y RNAs during apoptosis
105. Proteins phosphorylated during stress-induced apoptosis are common targets for autoantibody production in patients with systemic lupus erythematosus
106. Posttranslational protein modifications, apoptosis, and the bypass of tolerance to autoantigens
107. Cleavage by granzyme B is strongly predictive of autoantigen status: Implications for initiation of autoimmunity
108. Acquisition of granzyme B and Fas ligand proteins by human keratinocytes contributes to epidermal cell defense
109. Autoantibody recognition of distinctly modified forms of the U1-70-kd antigen is associated with different clinical disease manifestations
110. Bystander Apoptosis Triggers Dendritic Cell Maturation and Antigen-Presenting Function
111. Immature dendritic cells phagocytose apoptotic cells via alphavbeta5 and CD36, and cross-present antigens to cytotoxic T lymphocytes
112. Antigen capture, processing, and presentation by dendritic cells: Recent cell biological studies
113. Delayed clearance of apoptotic lymphoma cells allows cross-presentation of intracellular antigens by mature dendritic cells
114. Lymphocyte-mediated cytotoxicity: Two pathways and multiple effector molecules
115. Cytolytic T-cell cytotoxicity is mediated through perforin and Fas lytic pathways
116. Apoptosis and DNA fragmentation precede TNF-induced cytolysis in U937 cells
117. Induction of apoptotic nuclei by interferon-gamma and by predesquamin in cultured keratinocytes
118. Expression of Fas ligand and its receptor in cutaneous lupus: Implication in tissue injury
119. Autoantigens as substrates for apoptotic proteases: Implications for the pathogenesis of systemic autoimmune disease
120. Systemic exposure to irradiated apoptotic cells induces autoantibody production
121. A serological marker for neonatal lupus erythematosus
122. The autoantibody response to Ro/SSA in cutaneous lupus erythematosus
123. Anti-Ro/SSA antibodies in the pathophysiology of congenital heart block in neonatal lupus syndrome, an experimental model. In vitro electrophysiologic and immunocytochemical studies
124. Serum and immunoglobulin G from the mother of a child with congenital heart block induce conduction abnormalities and inhibit L-type calcium channels in a rat heart model
125. Cellular mechanism of the conduction abnormalities induced by serum from anti-Ro/SSA-positive patients in rabbit hearts
126. Induction of antibodies reactive with SSA/Ro-SSB/La and development of congenital heart block in a murine model
127. Autoantibody responses to the "native" 52- kDa SS-A/Ro protein in neonatal lupus syndromes, systemic lupus erythematosus, and Sjogren's syndrome
128. Apoptotic cell clearance in systemic lupus erythematosus. I. Opsonization by antiphospholipid antibodies
129. Dendritic cells preferentially internalize apoptotic cells opsonized by anti-beta2-glycoprotein I antibodies
130. Dendritic cell presentation of antigens from apoptotic cells in a proinflammatory context: Role of opsonizing anti-beta2-glycoprotein I antibodies
131. The specific recognition by macrophages of CD8+,CD45RO+ T cells undergoing apoptosis: A mechanism for T cell clearance during resolution of viral infections
132. C1q binds directly and specifically to surface blebs of apoptotic human keratinocytes: Complement deficiency and systemic lupus erythematosus revisited
133. Fine specificity of auto-antibodies to calreticulin: Epitope mapping and characterization
134. cDna cloning and primary structure analysis of C1qR(P), the human C1q/Mb1/Spa receptor that mediates enhanced phagocytosis in vitro
135. A hierarchical role for classical pathway complement proteins in the clearance of apoptotic cells in vivo
136. Hereditary C1q deficiency and systemic lupus erythematosus
137. Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies
138. Impaired phagocytosis of apoptotic cell material by monocyte-derived macrophages from patients with systemic lupus erythematosus
139. Evaluation of apoptotic cells induced by ultraviolet light B radiation in epidermal sheets stained by the TUNEL technique
140. The sunburn cell in mouse skin: Preliminary quantitative studies on its production
141. A receptor for phosphatidylserine-specific clearance of apoptotic cells
142. Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF
143. Transcriptional and translational regulation of inflammatory mediator production by endogenous TGF-beta in macrophages that have ingested apoptotic cells
144. Role of antigen-presenting cells in cross-priming of cytotoxic T lymphocytes by apoptotic cells
145. The formation of immunogenic major histocompatibility complex class II-peptide ligands in lysosomal compartments of dendritic cells is regulated by inflammatory stimuli
146. Stress proteins and the immune response
147. Stress proteins as molecular chaperones
148. Calreticulin, a peptide-binding chaperone of the endoplasmic reticulum, elicits tumor- and peptide-specific immunity
149. Heat shock proteins transfer peptides during antigen processing and CTL priming
150. TAP-translocated peptides specifically bind proteins in the endoplasmic reticulum, including gp96, protein disulfide isomerase and calreticulin
151. Identification of novel peptide binding proteins in the endoplasmic reticulum: ERp72, calnexin, and grp170
152. Restoration of MHC class I surface expression and endogenous antigen presentation by a molecular chaperone
153. Hsp72-mediated augmentation of MHC class I surface expression and endogenous antigen presentation
154. Heat shock proteins come of age: Primitive functions acquire new roles in an adaptive world
155. Heat shock proteins, tumor immunogenicity and antigen presentation: An integrated view
156. Stress proteins and immunity mediated by cytotoxic T lymphocytes
157. Immunotherapy of tumors with autologous tumor-derived heat shock protein preparations
158. The dual nature of specific immunological activity of tumor-derived gp96 preparations
159. Heat shock protein-peptide complexes, reconstituted in vitro, elicit peptide-specific cytotoxic T lymphocyte response and tumor immunity
160. Isolation of MHC class I-restricted tumor antigen peptide and its precursors associated with heat shock proteins hsp70, hsp90, and gp96
161. Cross-presentation of glycoprotein 96-associated antigens on major histocompatibility complex class I molecules requires receptor-mediated endocytosis
162. Saturation, competition, and specificity in interaction of heat shock proteins (hsp) gp96, hsp90, and hsp70 with CD11b+ cells
163. CD91: A receptor for heat shock protein gp96
164. gp96- the immune system's Swiss army knife
165. A mechanism for the specific immunogenicity of heat shock protein-chaperoned peptides
166. Heat shock protein 70 induced during tumor cell killing induces Th1 cytokines and targets immature dendritic cell precursors to enhance antigen uptake
167. The heat shock protein gp96 induces maturation of dendritic cells and down-regulation of its receptor
168. HSP70 stimulates cytokine production through a CD14-dependant pathway, demonstrating its dual role as a chaperone and cytokine
169. Induction of tumor peptide-specific cytotoxic T cells under serum-free conditions by mature human dendritic cells
170. Differential heat shock protein overexpression and its clinical relevance in systemic lupus erythematosus
171. Surface expression of heat shock protein 90 by blood mononuclear cells from patients with systemic lupus erythematosus
172. Elevated levels of the 90 kD heat shock protein in patients with systemic lupus erythematosus are dependent upon enhanced transcription of the hsp90 beta gene
173. The regulation of heat shock proteins and their role in systemic lupus erythematosus
174. Detection of autoantibodies to the 90 kDa heat shock protein in systemic lupus erythematosus and other autoimmune diseases
175. Incidence of anti Hsp 90 and 70 antibodies in children with SLE, juvenile dermatomyositis and juvenile chronic arthritis
176. Increased levels of antibodies to heat shock proteins with increasing age in Mr1/Mp-1pr/1pr mice
177. The tissue specific elevation in synthesis of the 90 kDa heat shock protein precedes the onset of disease in lupus prone MRL/lpr mice
178. Molecular chaperones are targets of autoimmunity in Ro(SS-A) immune mice
179. Systemic lupus erythematosus is associated with increased auto-antibody titers against calreticulin and grp94, but calreticulin is not the Ro/SSA antigen
180. The systemic lupus erythematosus (SLE) disease autoantigen-calreticulin can inhibit C1q association with immune complexes
181. Analysis of 70 KD heat shock protein (HSP70) expression in the lesional skin of lupus erythematosus (LE) and LE related diseases
182. Relationship between heat shock protein induction and the binding of antibodies to the extractable nuclear antigens on cultured human keratinocytes
183. Stress-induced cell surface expression and antigenic alteration of the Ro/SSA autoantigen
184. Tumor immunogenicity is determined by the mechanism of cell death via induction of heat shock protein expression
185. Apoptosis or necrosis for tumor immunotherapy: What's in a name?
186. Consequences of cell death: Exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells
187. Ultraviolet light modulation of autoantigens, epidermal cytokines and adhesion molecules as contributing factors of the pathogenesis of cutaneous LE
188. Evidence that DNA damage triggers interleukin 10 cytokine production in UV-irradiated murine keratinocytes
189. Activation of transcription factor AP-2 mediates UVA radiation- and singlet oxygen-induced expression of the human intercellular adhesion molecule 1 gene
190. Human keratinocytes are a source for tumor necrosis factor alpha: Evidence for synthesis and release upon stimulation with endotoxin or ultraviolet light
191. Expression of the tumor necrosis factor gene by dermal fibroblasts in response to ultraviolet irradiation or lipopolysaccharide
192. UV-A irradiation induces transcription of IL-6 and TNF alpha genes in human keratinocytes and dermal fibroblasts
193. Cis-urocanic acid suppression of contact hypersensitivity induction is mediated via tumor necrosis factor-alpha
194. Cytokine-induced ICAM-1 expression in human keratinocytes is highly variable in keratinocyte strains from different donors
195. Tumor necrosis factor: A master-regulator of leukocyte movement
196. Depressed Langerhans cell migration and reduced contact hypersensitivity response in mice lacking TNF receptor p75
197. Dendritic cells and the control of immunity
198. The temporal importance of TNFalpha expression in the development of diabetes
199. Enhanced membrane expression of the 52 kDa Ro(SS-A) and La(SS-B) antigens by human keratinocytes induced by TNF alpha
200. Cachexia and graft-vs.-host-disease-type skin changes in keratin promoter-driven TNF alpha transgenic mice
201. Serum IL-6, TNFalpha, p55 srTNFalpha, p75srTNFalpha, srIL-2alpha levels and disease activity in systemic lupus erythematosus
202. Thalidomide for recalcitrant discoid lesions in a patient with systemic lupus erythematosus
203. Thalidomide in the treatment of the cutaneous manifestations of lupus erythematosus: Experience in sixteen consecutive patients
204. American experience with low-dose thalidomide therapy for severe cutaneous lupus erythematosus
205. Thalidomide selectively inhibits tumor necrosis factor alpha production by stimulated human monocytes
206. Thalidomide and derivatives: Immunological investigations of tumour necrosis factor-alpha (TNF-alpha) inhibition suggest drugs capable of selective gene regulation
207. Interleukin 1 gene expression in cultured human keratinocytes is augmented by ultraviolet irradiation
208. Whole-body exposure to ultraviolet radiation results in increased serum interleukin-1 activity in humans
209. Interleukin-1 and cutaneous inflammation: A crucial link between innate and acquired immunity
210. Inflammatory skin disease in transgenic mice that express high levels of interleukin 1 alpha in basal epidermis
211. Cytokine modulation of keratinocyte cytokines
212. Mechanisms of cutaneous inflammation. Interactions between epidermal cytokines, adhesion molecules, and leukocytes
213. Evidence for an epidermal cytokine network
214. Cytokine networks in the skin
215. Expression of intercellular adhesion molecule-1 (ICAM-1) and OKM5 in UVA- and UVB-induced lesions in patients with lupus erythematosus and polymorphous light eruption
216. Adhesion of T lymphoblasts to epidermal keratinocytes is regulated by interferon gamma and is mediated by intercellular adhesion molecule 1 (ICAM-1)
217. Mechanism involved in the systemic suppression of antigen-presenting cell function by UV irradiation. Keratinocyte-derived IL-10 modulates antigen-presenting cell function of splenic adherent cells
218. Impaired immunosuppressive response to ultraviolet radiation in interleukin-10-deficient mice
219. Supernatants from UVB radiation-exposed keratinocytes inhibit Langerhans cell presentation of tumor-associated antigens via IL-10 content
220. IL-10 inhibits tumor antigen presentation by epidermal antigen-presenting cells
221. Post-transcriptional regulation of interleukin-6 gene expression in human keratinocytes by ultraviolet B radiation
222. Interleukin-10 activates heat-shock protein 90beta gene expression
223. Transcriptional regulation of the heat shock protein genes by STAT family transcription factors
224. Interleukin 6: Insights to its function in skin by overexpression in transgenic mice
225. Systemic suppression of delayed-type hypersensitivity by supernatants from UV-irradiated keratinocytes. An essential role for keratinocyte-derived IL-10
226. Enhanced epidermal Langerhans cell migration in IL-10 knockout mice
227. Interleukin-10 (IL-10) secretion in systemic lupus erythematosus and rheumatoid arthritis: IL-10-dependent CD4+CD45RO+ T cell-B cell antibody synthesis
228. Role of interleukin 10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus
229. Clinical and biologic effects of anti-interleukin-10 monoclonal antibody administration in systemic lupus erythematosus
230. Induction of proinflammatory cytokines in human epidermoid carcinoma cells by in vitro ultraviolet A1 irradiation
231. Dose-dependent induction of IL-12 but not IL-10 from human keratinocytes after exposure to ultraviolet light A
232. Modulation of IL-10, IL-12, and IFN-gamma in the epidermis of hairless mice by UVA (320-400 nm) and UVB (280-320 nm) radiation
233. Interleukin-12 prevents ultraviolet B-induced local immunosuppression and overcomes UVB-induced tolerance
234. T-cell cytokine network in cutaneous lupus erythematosus
235. T cell-mediated Fas-induced keratinocyte apoptosis plays a key pathogenetic role in eczematous dermatitis
236. Apoptosis is induced by anti-Fas antibody alone in cultured human keratinocytes
237. Keratinocytes constitutively express the Fas antigen that mediates apoptosis in IFN gamma-treated cultured keratinocytes
238. Transgenic mice expressing IFN-gamma in the epidermis have eczema, hair hypopigmentation, and hair loss
239. Antinuclear autoantibodies and lupus nephritis in transgenic mice expressing interferon gamma in the epidermis
240. A central role for alpha beta T cells in the pathogenesis of murine lupus
241. Does exposure to UV radiation induce a shift to a Th-2-like immune reaction?
242. Functional diversity of helper T lymphocytes
243. Photobiology of lupus erythematosus
244. Perturbation of experimental ultraviolet light-induced erythema by passive transfer of serum from subacute cutaneous lupus erythematosus patients
245. Passive transfer of photosensitivity by intradermal injection of vesiculobullous lupus erythematosus serum and ultraviolet light irradiation in the guinea pig
246. Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm
247. Inflammatory skin diseases, T cells, and immune surveillance
248. Increased serum levels of soluble L-selectin (CD62L) in patients with active systemic lupus erythematosus (SLE)
249. The expression of endothelial leukocyte adhesion molecule-1 (ELAM-1), intercellular adhesion molecule-1 (ICAM-1), and vascular cell adhesion molecule-1 (VCAM-1) in experimental cutaneous inflammation: A comparison erythema and delayed hypersensitivity
250. Early events in ultraviolet light-induced skin lesions in lupus erythematosus: Expression patterns of adhesion molecules ICAM-1, VCAM-1 and E-selectin
251. Different patterns of soluble adhesion molecules in systemic and cutaneous lupus erythematosus
252. Marked synergism between tumor necrosis factor-alpha and interferon-gamma in regulation of keratinocyte-derived adhesion molecules and chemotactic factors
253. TNF-alpha and IL-1 sequentially induce endothelial ICAM-1 and VCAM-1 expression in MRL/1pr lupus-prone mice
254. Tumor necrosis factor induced adhesion molecule serum concentrations in Henoch-Schonlein purpura and pediatric systemic lupus erythematosus
255. Up-regulation of endothelial cell adhesion molecules characterizes disease activity in systemic lupus erythematosus. The Shwartzman phenomenon revisited
256. VCAM-1 expression on endothelium in lesions from cutaneous lupus erythematosus is increased compared with systemic and localized scleroderma
257. Nitric oxide in systemic lupus erythematosus
258. Contrasting effects of NO and peroxynitrites on HSP70 expression and apoptosis in human monocytes
259. LPS induces apoptosis in macrophages mostly through the autocrine production of TNF-alpha
260. Nitric oxide inhibits apoptosis via AP-1-dependent CD95L transactivation
261. Release by ultraviolet B radiation of nitric oxide from human keratinocytes: A potential role for nitric oxide in erythema production
262. Aberrant timing in epidermal expression of inducible nitric oxide synthase after UV irradiation in cutaneous lupus erythematosus
263. Nitric oxide fully protects against UVA-induced apoptosis in tight correlation with Bcl-2 up-regulation
264. The inflammatory and cytotoxic effects of a nitric oxide releasing cream on normal skin
265. The role of nitric oxide in the pathogenesis of spontaneous murine autoimmune disease: Increased nitric oxide production and nitric oxide synthase expression in MRL/1pr mice, and reduction of spontaneous arthritis by orally administered NG-monomethyl-L-arginine
266. Effect of late modulation of nitric oxide on production of murine lupus
267. Increased nitric oxide production accompanied by the up-regulation of inducible nitric oxide synthase in vascular endothelium from patients with systemic lupus erythematosus
268. Prospective measure of serum 3-nitrotyrosine levels in systemic lupus erythematosus: Correlation with disease activity
269. Nitric oxide
270. Interleukin-1 receptor antagonist production by human keratinocytes
271. Interleukin-1 receptor antagonist gene polymorphism in Japanese patients with systemic lupus erythematosus
272. Interleukin-1 receptor antagonist gene polymorphism as a disease severity factor in systemic lupus erythematosus
273. Genetics of interleukin one receptor antagonist in inflammatory skin diseases
274. Genetic variation in the interleukin 10 gene promoter and systemic lupus erythematosus
275. Dysregulation of interleukin-10 production in relatives of patients with systemic lupus erythematosus
276. High interleukin-10 production in first-degree relatives of patients with generalized but not cutaneous lupus erythematosus
277. A promoter polymorphism of tumor necrosis factor alpha associated with systemic lupus erythematosus in African-Americans
278. TNF-308A and HLA-DR3 alleles contribute independently to susceptibility to systemic lupus erythematosus
279. In three types of interface dermatitis, different patterns of expression of intercellular adhesion molecule-1 (ICAM-1) indicate different triggers of disease
280. Strong association of a promoter polymorphism of tumor necrosis factor-alpha with a photosensitive form of cutaneous lupus erythematosus
281. An allelic polymorphism within the human tumor necrosis factor alpha promoter region is strongly associated with HLA A1, B8, and DR3 alleles
282. Homozygous C2 deficiency, lupus erythematosus, and anti-Ro (SSA) antibodies
283. Relationship between C4 null genes, HLA-D region antigens, and genetic susceptibility to systemic lupus erythematosus in Caucasian and black Americans
284. Subacute cutaneous lupus erythematosus in multiple members of a family with C2 deficiency
285. HLA genotypes in a family with a case of homozygous C2 deficiency and discoid lupus erythematosus
286. Genetic deficiency of C4, C2 or C1q and lupus syndromes. Association with anti-Ro (SS-A) antibodies
287. Complement deficiency and autoimmunity
288. Polymorphism in the tumor necrosis factor-alpha promotor region and in the heat shock protein 70 genes associated with malignant tumors
289. A rapid method to study heat shock protein 70-2 gene polymorphism in insulin-dependent diabetes mellitus
290. Serologic subsets in systemic lupus erythematosus: An examination of autoantibodies in relationship to clinical features of disease and HLA antigens
291. Serologic and HLA associations in subacute cutaneous lupus erythematosus, a clinical subset of lupus erythematosus
292. Association of anti-Ro/SS-A autoantibodies with glutamine in position 34 of DQA1 and leucine in position 26 of DQB1
293. Similar Ro/SS-A autoantibody epitope and titer responses in annular erythema of Sjogren's syndrome and subacute cutaneous lupus erythematosus
294. Neonatal lupus erythematosus: Analysis of HLA class II alleles in mothers and siblings from seven Japanese families
295. HLA class II phenotype controls diversification of the autoantibody response in primary Sjogren's syndrome (pSS)